Has Rupal Patel received payments from drug or device companies?

Yes. Drug and device makers reported $4,385 in general payments to Rupal Patel across 131 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rupal Patel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rupal Patel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rupal Patel

Psychiatric/Mental Health · Aiken, SCNPI 1083337745

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,293 of the $4,385 with a category attached, or 75.1%. 15 manufacturers reported payments, led by Johnson & Johnson at 41.9% of the total. Reporting peaked in 2023 at $2,748 and has fallen 87.3% since, to $349 in 2025.

$4,385in general payments, 2019–2025

Across 131 payments — averaging $33.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
AbbVie$529
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$421
Tris Pharma Inc$368
Otsuka America Pharmaceutical, Inc.$317
Axsome Therapeutics, Inc.$207
plus $707 from 9 others

What the payments were for

Travel & lodging$1,08025%
Food & beverage$3,29375%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	21	$1,837
AbbVie	30	$529
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	21	$421
Tris Pharma Inc	19	$368
Otsuka America Pharmaceutical, Inc.	7	$317
Axsome Therapeutics, Inc.	10	$207
Corium, LLC	3	$153
Boston Scientific	1	$133
Supernus Pharmaceuticals, Inc.	1	$127
Almatica Pharma LLC	5	$71
Ironshore Pharmaceuticals Inc.	3	$56
Noven Therapeutics, LLC	3	$54
Alkermes, Inc.	3	$49
Neos Therapeutics, LP	2	$33
Idorsia Pharmaceuticals US Inc	2	$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,385 in reported general payments places this provider in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.

See all psychiatric/mental health providers in South Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Alprazolam	17	$57
Alprazolam ErAlprazolam	12	$44

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Aiken

Jessa HollingsworthAiken$10K
Paul HeffingtonAiken$5K
Steven KrozerGreenville$139K
Luron FlemingGreenville$61K
Cerrissa HugieCharleston$54K
Karen FulwoodMyrtle Beach$30K
Taylor CrewsIsle Of Palms$28K
Lauren DyerGreenville$16K
Melissa BrownGreenville$16K
Mary McManusNorth Myrtle Beach$15K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →